Nothing Special   »   [go: up one dir, main page]

ES8702892A1 - 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use. - Google Patents

3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.

Info

Publication number
ES8702892A1
ES8702892A1 ES553087A ES553087A ES8702892A1 ES 8702892 A1 ES8702892 A1 ES 8702892A1 ES 553087 A ES553087 A ES 553087A ES 553087 A ES553087 A ES 553087A ES 8702892 A1 ES8702892 A1 ES 8702892A1
Authority
ES
Spain
Prior art keywords
atoms
nitro
hydrogen
image
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES553087A
Other languages
Spanish (es)
Other versions
ES553087A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8702892A1 publication Critical patent/ES8702892A1/en
Publication of ES553087A0 publication Critical patent/ES553087A0/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)

Abstract

Novel 3-nitro-dihydropyridine derivatives of the formula < IMAGE > in which R1 and R2 each independently is hydrogen, C1-C4-alkyl, C1-C12-alkoxy, C1-C4-halogenoalkoxy, halogen, nitro, C1-C4-halogenoalkyl, C1-C4-halogenoalkylmercapto, < IMAGE > Z is oxygen or sulphur, R4 and R5 each independently is hydrogen, C1-C4-alkyl, C1-C6-alkoxy, halogen, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy or nitro, or R1 and R2, together with 2 C atoms of the phenyl ring form the ring < IMAGE > X is oxygen or sulphur, A is a hydrocarbon radical with up to 12 C atoms which optionally contains one or two identical or different chain members from the group comprising O, S and CO and/or which is optionally substituted by hydroxyl or aliphatic acyloxy with up to 4 C atoms, R3 is -O-COR6, -S-CO-R6, SH, OH , NH2, < IMAGE > NH-COR6, COOR6, NR7R8 or CONR7R8, R6 is hydrogen or an aliphatic radical with up to 6 C atoms or a phenyl radical, and R7 and R8 each independently is hydrogen or an aliphatic radical with up to 6 C atoms or a phenyl radical, or a physiologically acceptable salts thereof, which are active in circulation and exhibit positive inotropic activity.
ES553087A 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use. Expired ES8702892A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843420784 DE3420784A1 (en) 1984-06-04 1984-06-04 3-NITRO-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS

Publications (2)

Publication Number Publication Date
ES8702892A1 true ES8702892A1 (en) 1987-01-16
ES553087A0 ES553087A0 (en) 1987-01-16

Family

ID=6237588

Family Applications (6)

Application Number Title Priority Date Filing Date
ES543838A Expired ES8607239A1 (en) 1984-06-04 1985-06-03 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES553087A Expired ES8702892A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES553088A Expired ES8702357A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES553085A Expired ES8702356A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES553089A Expired ES8702358A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES553086A Expired ES8702891A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES543838A Expired ES8607239A1 (en) 1984-06-04 1985-06-03 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES553088A Expired ES8702357A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES553085A Expired ES8702356A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES553089A Expired ES8702358A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES553086A Expired ES8702891A1 (en) 1984-06-04 1986-03-17 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.

Country Status (16)

Country Link
US (1) US4645775A (en)
EP (1) EP0164010B1 (en)
JP (1) JPH0670013B2 (en)
KR (1) KR860000262A (en)
AT (1) ATE40883T1 (en)
AU (1) AU4329485A (en)
DE (2) DE3420784A1 (en)
DK (1) DK248585A (en)
ES (6) ES8607239A1 (en)
FI (1) FI852204L (en)
GR (1) GR851313B (en)
HU (1) HU193986B (en)
IL (1) IL75364A0 (en)
NO (1) NO852024L (en)
PT (1) PT80579B (en)
ZA (1) ZA854163B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3617976A1 (en) * 1986-05-28 1988-01-14 Alter Sa 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN ANTITHROMBOTIC MEDICATIONS
DE3732380A1 (en) * 1987-09-25 1989-04-06 Bayer Ag DIHYDROPYRIDINETHER, METHOD FOR THEIR PRODUCTION AND THEIR USE
JPH02167262A (en) * 1988-06-05 1990-06-27 Taisho Pharmaceut Co Ltd 1,4-dihydropyridine derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752820A1 (en) * 1977-11-26 1979-05-31 Bayer Ag NEW NITRO-SUBSTITUTED 1,4-DIHYDROPYRIDINE, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3319956A1 (en) * 1983-06-01 1984-12-06 Bayer Ag, 5090 Leverkusen 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS
FR2554109A1 (en) * 1983-11-01 1985-05-03 Sandoz Sa NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND USE IN THERAPEUTICS AS MEDICAMENTS

Also Published As

Publication number Publication date
ES553086A0 (en) 1987-01-16
ES553088A0 (en) 1987-01-01
PT80579B (en) 1987-04-28
ES8702358A1 (en) 1987-01-01
DE3420784A1 (en) 1985-12-05
ZA854163B (en) 1986-01-29
HUT38313A (en) 1986-05-28
ATE40883T1 (en) 1989-03-15
DE3568330D1 (en) 1989-03-30
PT80579A (en) 1985-07-01
EP0164010B1 (en) 1989-02-22
JPH0670013B2 (en) 1994-09-07
FI852204A0 (en) 1985-05-31
DK248585A (en) 1985-12-05
ES8607239A1 (en) 1986-06-16
ES543838A0 (en) 1986-06-16
IL75364A0 (en) 1985-09-29
ES553087A0 (en) 1987-01-16
ES553089A0 (en) 1987-01-01
GR851313B (en) 1985-11-25
ES8702356A1 (en) 1987-01-01
FI852204L (en) 1985-12-05
NO852024L (en) 1985-12-05
ES553085A0 (en) 1987-01-01
HU193986B (en) 1987-12-28
EP0164010A3 (en) 1987-08-05
ES8702357A1 (en) 1987-01-01
US4645775A (en) 1987-02-24
ES8702891A1 (en) 1987-01-16
AU4329485A (en) 1985-12-12
JPS611660A (en) 1986-01-07
KR860000262A (en) 1986-01-27
EP0164010A2 (en) 1985-12-11
DK248585D0 (en) 1985-06-03

Similar Documents

Publication Publication Date Title
ES481129A1 (en) New substituted phenylpiperazine derivatives, pharmaceutical compositions containing them and process for their preparation.
ES8402261A1 (en) Omega-cyano-1, omega-diphenyl azalcane derivatives, their preparation and pharmaceutical preparations containing them.
ES8107216A1 (en) 1-Piperidinesulfonyl ureas, processes for their preparation, pharmaceutical compositions based on these compounds and their use.
MX9206082A (en) AMIDA DERIVATIVES OF N-PHENYL-2-CIANO-3-HYDROXICROTONIC ACID AND ITS USE AS MEDICINES WITH IMMUNOMODULATING PROPERTIES.
ES8702891A1 (en) 3-Nitro-dihydropyridines, process for their preparation and their pharmaceutical use.
ES8106304A1 (en) 7-Phenyl-quinolizidine derivatives (I), their preparation, pharmaceutical compositions containing them and (I) for use in treating diseases.
ES480113A1 (en) Derivatives of 2-imino-imidazolidine, processes for their preparation, pharmaceutical compositions containing them and intermediates.
DE59303456D1 (en) ALLYLAMINO NITRO FLAVORS
ES474694A1 (en) 7-Amino-5H-benzocycloheptene derivatives and their salts, a process for their preparation, their use as medicines and pharmaceutical compositions containing them.
DE3474669D1 (en) 1,4-dihydropyridines, method for their preparation and their use as medicaments
ATE101119T1 (en) Butynoamides, their salts, pharmaceutical compositions containing them and processes for their preparation.
ES2009283A6 (en) Aminoacylates of glycerol acetal